REQUEST A DEMO
Total
USD $0.00
Search more companies

Lucrose Pharma Private Limited (India)

Main Activities: Other Business Support Services
Full name: Lucrose Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lucrose Pharma Private Limited is an unlisted company, incorporated on 14/07/2016. It has its registered office in the State of Uttar Pradesh, India. Company's corporate identification number (CIN) is U74999UP2016PTC084888 and registration number is 084888. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Part Of Plot No 7 Tirupati Industrial Estate, Mohkampur
Meerut; Uttar Pradesh; Postal Code: 250002

Contact Details: Purchase the Lucrose Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Lucrose Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Lucrose Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Lucrose Pharma Private Limited report to view the information.
Incorporation Date:
July 14, 2016
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Subsidiaries
Diggal Pharma Private Limited
100%
Lucrose Agro Private Limited
55%
Company Performance
Financial values in the chart are available after Lucrose Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
26.45%
Total operating revenue
26.43%
Operating profit (EBIT)
83.77%
EBITDA
68.96%
Net Profit (Loss) for the Period
85.11%
Total assets
43.25%
Total equity
36.8%
Operating Profit Margin (ROS)
1.32%
Net Profit Margin
0.92%
Return on Equity (ROE)
7.02%
Debt to Equity Ratio
23.92%
Quick Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?